Integra LifeSciences Holdings Capital Reinvestment Ratio
Integra LifeSciences Holdings capital reinvestment ratio. Integra LifeSciences Holdings (IART) has a Capital Reinvestment Ratio of 1.51x as of March 2026, meaning it reinvests 2% of its operating cash flow ($9.80 Million) in capital expenditures ($14.85 Million). See IART free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Integra LifeSciences Holdings (1999–2025)
Capital reinvestment ratio of Integra LifeSciences Holdings from 1999 to 2025. This chart tracks Integra LifeSciences Holdings's Capital Reinvestment Ratio across 26 annual periods. See IART free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Integra LifeSciences Holdings Capital Reinvestment Ratio by Year (1999–2025)
Integra LifeSciences Holdings capital reinvestment ratio by year from 1999 to 2025. For the full cash flow conversion analysis, see IART operating cash flow.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.62x | $50.38 Million | $81.44 Million | ▲ +100.3% |
| 2024 | 0.81x | $129.38 Million | $104.42 Million | ▲ +68.9% |
| 2023 | 0.48x | $139.96 Million | $66.86 Million | ▲ +168.4% |
| 2022 | 0.18x | $264.47 Million | $47.09 Million | ▲ +15.7% |
| 2021 | 0.15x | $312.43 Million | $48.08 Million | ▼ -50.9% |
| 2020 | 0.31x | $203.83 Million | $63.89 Million | ▼ -46.1% |
| 2019 | 0.58x | $231.43 Million | $134.53 Million | ▲ +49.3% |
| 2018 | 0.39x | $199.68 Million | $77.74 Million | ▲ +2.5% |
| 2017 | 0.38x | $114.54 Million | $43.50 Million | ▼ -6.6% |
| 2016 | 0.41x | $116.41 Million | $47.33 Million | ▲ +15.0% |
| 2015 | 0.35x | $94.48 Million | $33.41 Million | ▼ -33.7% |
| 2014 | 0.53x | $79.46 Million | $42.40 Million | ▼ -40.6% |
| 2013 | 0.90x | $53.27 Million | $47.85 Million | ▼ -23.6% |
| 2012 | 1.18x | $58.72 Million | $69.03 Million | ▲ +219.2% |
| 2011 | 0.37x | $104.33 Million | $38.42 Million | ▲ +4.7% |
| 2010 | 0.35x | $105.57 Million | $37.14 Million | ▲ +82.8% |
| 2009 | 0.19x | $143.24 Million | $27.57 Million | ▲ +4.3% |
| 2008 | 0.18x | $72.59 Million | $13.40 Million | ▼ -61.5% |
| 2007 | 0.48x | $47.03 Million | $22.57 Million | ▲ +198.8% |
| 2006 | 0.16x | $71.70 Million | $11.52 Million | ▲ +13.4% |
| 2005 | 0.14x | $56.85 Million | $8.05 Million | ▼ -35.1% |
| 2004 | 0.22x | $38.98 Million | $8.51 Million | ▲ +97.8% |
| 2003 | 0.11x | $34.83 Million | $3.84 Million | ▲ +56.6% |
| 2002 | 0.07x | $31.98 Million | $2.25 Million | ▼ -61.3% |
| 2001 | 0.18x | $15.70 Million | $2.86 Million | ▼ -97.4% |
| 1999 | 6.92x | $2.50 Million | $17.30 Million | — |